Funding Details
- Awarder
- Inbox
- Date Award
- December 04, 2017
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
Company Info
- Founders
- Prof. Raymond Kaempfer, Dr. Gila Arad
- Company Description
- Atox Bio is a late stage clinical biotechnology company that develops novel immune modulators for critically ill patients with severe infections.
- Market
- Healthcare
- Location
-
Israel
- Coinvestors
- Adams Street Partners, Arix Bioscience, Asahi Kasei Integra Holdings, Lundbeckfond Ventures, OrbiMed Advisors, SR One
Links